L. Ferrari

发表

Practical considerations in enhancing LC-MS sensitivity for therapeutic protein bioanalysis.

Shaolian Zhou, F. Vazvaei, J. Qu, 2017, Bioanalysis.

High-Throughput, Sensitive LC-MS Quantification of Biotherapeutics and Biomarkers Using Antibody-Free, Peptide-Level, Multiple-Mechanism Enrichment via Strategic Regulation of pH and Ionic and Solvent Strengths.

Shaolian Zhou, L. Benincosa, Xue Wang, 2019, Analytical chemistry.

Toward Accurate and Robust Liquid Chromatography-Mass Spectrometry-Based Quantification of Antibody Biotherapeutics in Tissues.

Shaolian Zhou, F. Vazvaei, Bo An, 2020, Analytical chemistry.

Novel vaginal delivery systems for calcitonin: II. Preparation and characterization of HYAFF® microspheres containing calcitonin

L. Benedetti, J. L. Richardson, M. Miglietta, 1996 .

Determination of casopitant and its three major metabolites in dog and rat plasma by positive ion liquid chromatography/tandem mass spectrometry.

L. Ferrari, D. Reami, M. Michi, 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Ampicillin sodium: Isolation, identification and synthesis of the last unknown impurity after 60 years of clinical use.

W. Cabri, A. Ricci, G. Martelli, 2020, Journal of pharmaceutical and biomedical analysis.

Separation, characterization, and analysis of epirubicin (4'-epidoxorubicin) and its metabolites from human urine.

S. Penco, G. Cassinelli, F. Arcamone, 1984, Drug metabolism and disposition: the biological fate of chemicals.

Validation of a high-sensitivity assay for zatebradine in dried blood spots of human blood at pg/ml concentrations using HILIC-MS/MS.

L. Ferrari, M. Michi, 2010, Bioanalysis.

2018 White Paper on Recent Issues in Bioanalysis: focus on immunogenicity assays by hybrid LBA/LCMS and regulatory feedback (Part 2 - PK, PD & ADA assays by hybrid LBA/LCMS & regulatory agencies' inputs on bioanalysis, biomarkers and immunogenicity).

Eric Woolf, Akiko Ishii-Watabe, Naidong Weng, 2018, Bioanalysis.

Tissue Distribution and Characterization of Drug-Related Material in Rats and Dogs after Repeated Oral Administration of Casopitant

M. Pellegatti, D. Cufari, E. Bordini, 2011, Drug Metabolism and Disposition.

LC-MS/MS determination of alectinib and its major human metabolite M4 in human urine: prevention of nonspecific binding.

Luca Ferrari, Katja Heinig, Kazuhiro Miya, 2017, Bioanalysis.

Sensitive, High-Throughput, and Robust Trapping-Micro-LC-MS Strategy for the Quantification of Biomarkers and Antibody Biotherapeutics.

J. Canty, Shaolian Zhou, R. Young, 2018, Analytical chemistry.

2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV) (Part 1 - small molecules, peptides and small molecule biomarkers by LCMS).

Stephanie Cape, Scott Summerfield, Amanda Wilson, 2016, Bioanalysis.